GlassScriptPhysician profile
Jose R Antunes
NPI 1720032253
$2,231.97
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,050 · 2020: $519 · 2021: $306 · 2022: $357.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mannkind Corporation | $582.31 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $337.72 | 2019-2021 | |
| Novo Nordisk INC | $255.42 | 2019-2022 | |
| Amgen INC. | $199.38 | 2019 | |
| Dexcom, INC. | $165.49 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $126.61 | 2019-2022 | |
| Lifescan, INC. | $87.73 | 2020-2022 | |
| Abbott Laboratories | $69.49 | 2019-2022 | |
| Insulet Corporation | $62.36 | 2019-2020 | |
| Antares Pharma, INC. | $51.09 | 2019-2021 | |
| Lilly USA, LLC | $50.89 | 2019-2022 | |
| Xeris Pharmaceuticals, INC. | $39.90 | 2020 | |
| Amarin Pharma, INC. | $35.95 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $33.57 | 2019 | |
| Aytu Biopharma, INC. | $27.68 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $26.42 | 2019 | |
| Ascensia Diabetes Care US INC. | $19.90 | 2020 | |
| Radius Health, INC. | $16.65 | 2020 | |
| Ibsa Pharma INC. | $14.95 | 2019 | |
| Shire North American Group INC | $14.56 | 2019 | |
| Esperion Therapeutics, INC. | $13.90 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Antunes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.